RENAL CELL CARCINOMA
Clinical trials for RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new treatment called GCAR1, which uses a patient's own immune cells modified to attack tumors that have a specific marker (GPNMB). It is for people with advanced alveolar soft part sarcoma, renal cell carcinoma, or triple-negative breast cancer that…
Matched conditions: RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 26, 2026 06:59 UTC
-
New drug cocktail aims to shrink kidney tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of three drugs (pembrolizumab, belzutifan, and lenvatinib) before surgery can shrink kidney tumors in people with localized clear cell renal cell carcinoma. About 150 participants will receive the drugs for 12 weeks, then have surgery…
Matched conditions: RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Kidney cancer patients may get a break from treatment with targeted therapy
Disease control Not yet recruitingThis study tests whether giving focused radiation or surgery to all remaining cancer spots can allow kidney cancer patients to stop their regular treatment for at least a year. It involves 23 adults with metastatic clear cell kidney cancer who have already had stable or improved …
Matched conditions: RENAL CELL CARCINOMA
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Experimental pill tested on patients with advanced cancers
Disease control Not yet recruitingThis is the first human study of an experimental oral drug called ACC-1898 for adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and understand how the body processes the drug. Participants will take dail…
Matched conditions: RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: AccSalus Biosciences, Inc. • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
New PET scan may grade kidney tumors without a biopsy
Diagnosis Not yet recruitingThis study will test whether a special PET scan using a tracer called 82-Rb can accurately tell how aggressive a kidney tumor is. Researchers will compare the scan results with the actual tumor grade after surgery. The goal is to see if the scan can identify high-grade (more dang…
Matched conditions: RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated May 26, 2026 06:59 UTC
-
A simple urine test could revolutionize kidney cancer diagnosis
Diagnosis Not yet recruitingThis study aims to find protein markers in urine and blood that can help doctors identify different types of kidney cancer without needing a tissue biopsy. Researchers will analyze stored urine samples and collect blood from 300 patients before and after kidney surgery. The goal …
Matched conditions: RENAL CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 26, 2026 06:47 UTC